The cost of US pharmaceutical price reductions: a financial simulation model of R&D decisions
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2005
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
11114 |
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Beschreibung: | 35 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023591323 | ||
| 003 | DE-604 | ||
| 005 | 20100217 | ||
| 007 | t | ||
| 008 | 051020s2005 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)254491366 | ||
| 035 | |a (DE-599)BVBBV023591323 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 100 | 1 | |a Abbott, Thomas A. |e Verfasser |0 (DE-588)130457035 |4 aut | |
| 245 | 1 | 0 | |a The cost of US pharmaceutical price reductions |b a financial simulation model of R&D decisions |c Thomas A. Abbott ; John A. Vernon |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2005 | |
| 300 | |a 35 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11114 | |
| 650 | 4 | |a Pharmazeutisches Produkt / Pharmazeutische Industrie / Staatliche Preispolitik / Cash Flow / Gewinn / Forschung / Simulation / USA | |
| 700 | 1 | |a Vernon, John A. |e Verfasser |0 (DE-588)130457043 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11114 |w (DE-604)BV002801238 |9 11114 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w11114.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016906653 | ||
Datensatz im Suchindex
| _version_ | 1804138248543404032 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Abbott, Thomas A. Vernon, John A. |
| author_GND | (DE-588)130457035 (DE-588)130457043 |
| author_facet | Abbott, Thomas A. Vernon, John A. |
| author_role | aut aut |
| author_sort | Abbott, Thomas A. |
| author_variant | t a a ta taa j a v ja jav |
| building | Verbundindex |
| bvnumber | BV023591323 |
| ctrlnum | (OCoLC)254491366 (DE-599)BVBBV023591323 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01402nam a2200325zcb4500</leader><controlfield tag="001">BV023591323</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100217 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051020s2005 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)254491366</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591323</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Abbott, Thomas A.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130457035</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The cost of US pharmaceutical price reductions</subfield><subfield code="b">a financial simulation model of R&D decisions</subfield><subfield code="c">Thomas A. Abbott ; John A. Vernon</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">35 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11114</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmazeutisches Produkt / Pharmazeutische Industrie / Staatliche Preispolitik / Cash Flow / Gewinn / Forschung / Simulation / USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vernon, John A.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130457043</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11114</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">11114</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w11114.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016906653</subfield></datafield></record></collection> |
| id | DE-604.BV023591323 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:28Z |
| indexdate | 2024-07-09T21:25:10Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016906653 |
| oclc_num | 254491366 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 35 S. graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Abbott, Thomas A. Verfasser (DE-588)130457035 aut The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions Thomas A. Abbott ; John A. Vernon Cambridge, Mass. National Bureau of Economic Research 2005 35 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11114 Pharmazeutisches Produkt / Pharmazeutische Industrie / Staatliche Preispolitik / Cash Flow / Gewinn / Forschung / Simulation / USA Vernon, John A. Verfasser (DE-588)130457043 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11114 (DE-604)BV002801238 11114 http://papers.nber.org/papers/w11114.pdf kostenfrei Volltext |
| spellingShingle | Abbott, Thomas A. Vernon, John A. The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Pharmazeutisches Produkt / Pharmazeutische Industrie / Staatliche Preispolitik / Cash Flow / Gewinn / Forschung / Simulation / USA |
| title | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions |
| title_auth | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions |
| title_exact_search | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions |
| title_exact_search_txtP | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions |
| title_full | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions Thomas A. Abbott ; John A. Vernon |
| title_fullStr | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions Thomas A. Abbott ; John A. Vernon |
| title_full_unstemmed | The cost of US pharmaceutical price reductions a financial simulation model of R&D decisions Thomas A. Abbott ; John A. Vernon |
| title_short | The cost of US pharmaceutical price reductions |
| title_sort | the cost of us pharmaceutical price reductions a financial simulation model of r d decisions |
| title_sub | a financial simulation model of R&D decisions |
| topic | Pharmazeutisches Produkt / Pharmazeutische Industrie / Staatliche Preispolitik / Cash Flow / Gewinn / Forschung / Simulation / USA |
| topic_facet | Pharmazeutisches Produkt / Pharmazeutische Industrie / Staatliche Preispolitik / Cash Flow / Gewinn / Forschung / Simulation / USA |
| url | http://papers.nber.org/papers/w11114.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT abbottthomasa thecostofuspharmaceuticalpricereductionsafinancialsimulationmodelofrddecisions AT vernonjohna thecostofuspharmaceuticalpricereductionsafinancialsimulationmodelofrddecisions |